Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways
Pharmaceuticals · 26.07.2025 · 18 (8) · 1115
DOI: 10.3390/ph18081115 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 26.07.2025. Verfasst von Sarfaraz K Niazi. Beteiligte Einrichtung: College of Pharmacy, University of Illinois, Chicago, IL 60612, USA. Die Arbeit wurde bisher 60-mal zitiert (Crossref) und nennt 190 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The escalating global crisis of antimicrobial resistance, responsible for approximately 1.27 million deaths in 2019, has catalyzed renewed interest in bacteriophage therapy as a viable therapeutic alternative. With projections indicating that drug-resistant bacteria could cause over 39 million deaths worldwide by 2050, developing alternative antimicrobial strategies has become critically urgent. This comprehensive review examines the scientific foundation of bacteriophage therapy, traces its historical development from early Soviet applications through contemporary regulatory frameworks, and provides strategic guidance for developers seeking FDA approval for bacteriophage-based therapeutics. We analyze the current regulatory landscape across major jurisdictions, including manufacturing requirements and clinical development pathways essential for successful market authorization. Approximately 90 clinical trials involving bacteriophages are ongoing worldwide, with 41 studies in the United States demonstrating significant momentum in this field.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- College of Pharmacy, University of Illinois, Chicago, IL 60612, USA.
ORCID-Profile: Sarfaraz K Niazi
Zitieren
APA
Niazi, S. K. (2025). Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways. Pharmaceuticals, 18(8), 1115. https://doi.org/10.3390/ph18081115
Vancouver
Niazi SK. Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways. Pharmaceuticals. 2025;18(8):1115. doi:10.3390/ph18081115
BibTeX
@article{Niazi2025,
author = {Niazi, Sarfaraz K},
title = {Bacteriophage Therapy: Discovery, Development, and FDA Approval Pathways},
journal = {Pharmaceuticals},
year = {2025},
volume = {18},
number = {8},
pages = {1115},
doi = {10.3390/ph18081115}
}
EUVIMED